Clinical trial
The Second Multicenter Hemophilia Cohort Study
NCT00341705 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00341705 |
|---|---|
| Title | The Second Multicenter Hemophilia Cohort Study |
| Official title | The Second Multicenter Hemophilia Cohort Study |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | Multicenter Hemophilia Cohort Study |
| Status | Completed |
| Study type | Observational |
| Conditions | Liver Decompensation, Hepatocellular Carcinoma, Non-Hodgkin Lymphoma |
| Enrollment | 2,565 |
| Start date | Apr 27, 2001 |
| Completion | Apr 2, 2013 |
| First posted | Jun 21, 2006 |
| Last update posted | Dec 17, 2019 |
| Countries | Brazil, Canada, France, Germany, Greece, Italy, Sweden, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: